Xiuli Guo

3.5k total citations
87 papers, 2.7k citations indexed

About

Xiuli Guo is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Xiuli Guo has authored 87 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 22 papers in Cancer Research and 20 papers in Immunology. Recurrent topics in Xiuli Guo's work include Galectins and Cancer Biology (13 papers), Drug Transport and Resistance Mechanisms (9 papers) and MicroRNA in disease regulation (8 papers). Xiuli Guo is often cited by papers focused on Galectins and Cancer Biology (13 papers), Drug Transport and Resistance Mechanisms (9 papers) and MicroRNA in disease regulation (8 papers). Xiuli Guo collaborates with scholars based in China, United Kingdom and Australia. Xiuli Guo's co-authors include Lu‐Gang Yu, Zhan‐Qi Cao, Qicheng Zhao, Jonathan M. Rhodes, Xiaoxia Yang, Huihui Zhang, Lei Wang, Chao Sun, John Hilkens and Hannah Barrow and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

Xiuli Guo

83 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiuli Guo China 28 1.7k 688 585 565 243 87 2.7k
Dipak Datta India 30 1.1k 0.7× 469 0.7× 287 0.5× 691 1.2× 159 0.7× 84 2.5k
Min Xiao China 24 1.6k 0.9× 314 0.5× 601 1.0× 624 1.1× 499 2.1× 73 3.0k
Karuppaiyah Selvendiran United States 35 1.8k 1.0× 268 0.4× 854 1.5× 687 1.2× 255 1.0× 67 3.1k
Quansheng Zhou China 37 2.3k 1.3× 871 1.3× 519 0.9× 640 1.1× 200 0.8× 89 3.7k
Ladislav Anděra Czechia 29 1.9k 1.1× 358 0.5× 435 0.7× 778 1.4× 175 0.7× 79 2.7k
Dexin Kong China 32 1.9k 1.1× 247 0.4× 534 0.9× 606 1.1× 320 1.3× 120 3.1k
Jie Ma China 28 1.5k 0.9× 327 0.5× 490 0.8× 420 0.7× 180 0.7× 210 2.9k
Devasis Chatterjee United States 20 2.2k 1.3× 393 0.6× 601 1.0× 760 1.3× 172 0.7× 44 3.0k
Sanjeev K. Srivastava United States 35 2.1k 1.2× 461 0.7× 1.4k 2.3× 980 1.7× 142 0.6× 62 3.4k

Countries citing papers authored by Xiuli Guo

Since Specialization
Citations

This map shows the geographic impact of Xiuli Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiuli Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiuli Guo more than expected).

Fields of papers citing papers by Xiuli Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiuli Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiuli Guo. The network helps show where Xiuli Guo may publish in the future.

Co-authorship network of co-authors of Xiuli Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiuli Guo. A scholar is included among the top collaborators of Xiuli Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiuli Guo. Xiuli Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Linzhi, Ji Qian, Xiuli Guo, et al.. (2025). Radiotherapy in combination with PD-1 and TIGIT blockade mediate antitumor abscopal effects and immune memory via CD8+ T cells. Cancer Letters. 631. 217935–217935. 1 indexed citations
2.
Wang, Yuanxin, et al.. (2025). Exosomal lncRNA MIR210HG derived from hypoxic TAMs promotes the metastasis of triple negative breast cancer. International Immunopharmacology. 165. 115416–115416. 1 indexed citations
3.
4.
Liu, Yifan, Li Feng, Wengeng Zhang, et al.. (2025). CYP2A6 suppresses hepatocellular carcinoma via inhibiting SRC/Wnt/β-Catenin pathway. Acta Pharmacologica Sinica. 46(7). 2029–2040.
5.
6.
Zhao, Lin, Bingling Zhong, Yanyan Zhu, et al.. (2023). Nitrovin (difurazone), an antibacterial growth promoter, induces ROS-mediated paraptosis-like cell death by targeting thioredoxin reductase 1 (TrxR1). Biochemical Pharmacology. 210. 115487–115487. 15 indexed citations
7.
Zhou, Yue, Shang Chen, Mengmeng Wang, et al.. (2021). Downregulation of Renal MRPs Transporters in Acute Lymphoblastic Leukemia Mediated by the IL-6/STAT3/PXR Signaling Pathway. Journal of Inflammation Research. Volume 14. 2239–2252. 7 indexed citations
8.
Wang, Lei, Lin Zhao, Chao Sun, et al.. (2021). Modified citrus pectin inhibits breast cancer development in mice by targeting tumor-associated macrophage survival and polarization in hypoxic microenvironment. Acta Pharmacologica Sinica. 43(6). 1556–1567. 21 indexed citations
9.
Zhou, Yue, Bin Du, Min‐Yen Kan, et al.. (2020). Drug Elimination Alteration in Acute Lymphoblastic Leukemia Mediated by Renal Transporters and Glomerular Filtration. Pharmaceutical Research. 37(8). 158–158. 7 indexed citations
10.
Li, Xiaotong, Yingshuang Li, Zhaoyu Shi, & Xiuli Guo. (2020). New insights into molecular chaperone TRAP1 as a feasible target for future cancer treatments. Life Sciences. 254. 117737–117737. 9 indexed citations
11.
Guo, Su, Xiuli Guo, Rui Yang, et al.. (2017). MicroRNA-645 is an oncogenic regulator in colon cancer. Oncogenesis. 6(5). e335–e335. 24 indexed citations
12.
Tian, Bing, et al.. (2017). Repositioning of proton pump inhibitors in cancer therapy. Cancer Chemotherapy and Pharmacology. 80(5). 925–937. 53 indexed citations
13.
14.
Zhang, Peng, Jinhua Chen, & Xiuli Guo. (2012). New insights into PTEN regulation mechanisms and its potential function in targeted therapies. Biomedicine & Pharmacotherapy. 66(7). 485–490. 17 indexed citations
15.
16.
Zhang, Peng, et al.. (2012). Sorcin, a potential therapeutic target for reversing multidrug resistance in cancer. Journal of Physiology and Biochemistry. 68(2). 281–287. 13 indexed citations
17.
Guo, Su, Xiuli Guo, Rongrong Yang, et al.. (2012). MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer. Oncogene. 32(15). 1910–1920. 186 indexed citations
18.
Barrow, Hannah, Xiuli Guo, Hans H. Wandall, et al.. (2011). Serum Galectin-2, -4, and -8 Are Greatly Increased in Colon and Breast Cancer Patients and Promote Cancer Cell Adhesion to Blood Vascular Endothelium. Clinical Cancer Research. 17(22). 7035–7046. 139 indexed citations
19.
Zhai, Li, et al.. (2011). Cytoprotective effects of CSTMP, a novel stilbene derivative, against H2O2-induced oxidative stress in human endothelial cells. Pharmacological Reports. 63(6). 1469–1480. 37 indexed citations
20.
Zhao, Qicheng, Xiuli Guo, Gerard B. Nash, et al.. (2009). Circulating Galectin-3 Promotes Metastasis by Modifying MUC1 Localization on Cancer Cell Surface. Cancer Research. 69(17). 6799–6806. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dipak Datta Breakdown of academic impact, for papers by Min Xiao Breakdown of academic impact, for papers by Karuppaiyah Selvendiran Breakdown of academic impact, for papers by Quansheng Zhou Breakdown of academic impact, for papers by Ladislav Anděra Breakdown of academic impact, for papers by Dexin Kong Breakdown of academic impact, for papers by Jie Ma Breakdown of academic impact, for papers by Devasis Chatterjee Breakdown of academic impact, for papers by Sanjeev K. Srivastava
Rankless by CCL
2026